Literature DB >> 19268306

Paraoxonase activity and dementia.

Hanna Wehr1, Małgorzata Bednarska-Makaruk, Ałła Graban, Wanda Lipczyńska-Łojkowska, Maria Rodo, Anna Bochyńska, Danuta Ryglewicz.   

Abstract

Paraoxonase activity, homocysteine level and lipids were determined in 120 patients with dementia (51 with Alzheimer disease, 28 with dementia of vascular origin, 41 with mixed dementia), 45 with mild cognitive impairment and in 61 age and sex matched controls without dementia. Paraoxonase activity was decreased in Alzheimer disease and in mixed dementia as compared with control group. In the same forms of dementia homocysteine levels were increased. In Alzheimer disease paraoxonase activity was negatively correlated with homocysteine levels. Minimental State Examination results showed positive correlation with paraoxonase activity. The results suggest an important role of oxidative stress in the development of the forms of dementia with prevailing neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268306     DOI: 10.1016/j.jns.2009.02.317

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.

Authors:  Kamila Borowczyk; Diana M Shih; Hieronim Jakubowski
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease.

Authors:  Porat M Erlich; Kathryn L Lunetta; L Adrienne Cupples; Carmela R Abraham; Robert C Green; Clinton T Baldwin; Lindsay A Farrer
Journal:  Neurobiol Aging       Date:  2010-10-27       Impact factor: 4.673

Review 3.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

4.  Organophosphate pesticides and PON1 L55M in Parkinson's disease progression.

Authors:  Kimberly C Paul; Janet S Sinsheimer; Myles Cockburn; Jeff M Bronstein; Yvette Bordelon; Beate Ritz
Journal:  Environ Int       Date:  2017-07-06       Impact factor: 9.621

5.  Pon1 Deficiency Promotes Trem2 Pathway-Mediated Microglial Phagocytosis and Inhibits Pro-inflammatory Cytokines Release In Vitro and In Vivo.

Authors:  Li Zhang; Wei Dong; Yuanwu Ma; Lin Bai; Xu Zhang; Caixian Sun; Jingwen Li; Lianfeng Zhang
Journal:  Mol Neurobiol       Date:  2022-05-19       Impact factor: 5.590

6.  Role of paraoxonase-1 in the protection of hydrogen sulfide-donating sildenafil (ACS6) against homocysteine-induced neurotoxicity.

Authors:  Xiao-Qing Tang; Rong-Qian Chen; Ling Dong; Yan-Kai Ren; Piero Del Soldato; Anna Sparatore; Duan-Fang Liao
Journal:  J Mol Neurosci       Date:  2012-07-29       Impact factor: 3.444

Review 7.  Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.

Authors:  Carlo Cervellati; Giuseppe Valacchi; Veronica Tisato; Giovanni Zuliani; Judit Marsillach
Journal:  Minerva Med       Date:  2018-10-11       Impact factor: 4.806

Review 8.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

9.  Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment.

Authors:  Joanna Perła-Kaján; Olga Włoczkowska; Anetta Zioła-Frankowska; Marcin Frankowski; A David Smith; Celeste A de Jager; Helga Refsum; Hieronim Jakubowski
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases.

Authors:  Necat Yilmaz
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.